The HFPN and 27 organisations demand urgent EU action on heart failure

News & Events

7 September 2021

The Heart Failure Policy Network has launched the Action Statement on Heart Failure, urging European institutions to address the growing burden of heart failure in the EU.

To summarise, the Action Statement:

The statement emphasises the EU’s vital role in providing political, strategic and financial support to help Member States reduce the impact of heart failure on people, healthcare systems and economies. Such efforts are essential to tackle healthcare backlogs from the COVID-19 pandemic, prevent hospitalisations, protect the quality of life and mental health of EU citizens, reduce inequalities and secure the EU’s leading position in healthcare research and innovation.

‘It is of serious concern that most European countries and the EU have no clear vision or strategy on how to address heart failure, the leading cause of preventable hospitalisations’, says Ed Harding, HFPN Network Director. ‘The EU can play a huge role in accelerating improvement efforts and galvanising political will. If we do not improve on the systemic failures that characterise the past decade of CVD prevention and management, heart failure and other cardiovascular conditions will continue to stretch our health systems and economies to their limits well beyond the COVID-19 pandemic.’

Find out more and download the Action Statement on Heart Failure here.

Read the full press release here.


More from News & Events

The HFPN Trailblazers Hub: supporting peer learning among he
The HFPN Trailblazers Hub: supporting peer learning among he...
19 October 2021
The Heart Failure Policy Network is delighted to announce the launch of the Trailblazers Hub, a new online resource showcasing examples of inspirational system transformation and p...
Read article
Register now for the Heart Failure Policy Summit
Register now for the Heart Failure Policy Summit...
05 October 2021
Join the Heart Failure Policy Network for the inaugural Heart Failure Policy Summit (16–18 November) – a new virtual event dedicated to the heart failure policy and advocacy co...
Read article
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma, Bayer AG, Boehringer Ingelheim and Novartis Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.